Literature DB >> 21082351

Altered expression and localization of connexin32 in human and murine gastric carcinogenesis.

Hyang Jee1, Ki Taek Nam, Hyo-Jung Kwon, Sang-Uk Han, Dae-Yong Kim.   

Abstract

BACKGROUND: Intercellular communication via gap junctions, composed of protein subunits called connexins (Cxs), plays a key role in controlling cell growth, differentiation and carcinogenesis. Impaired gap junctional intercellular communication has been reported in various cancers and diseases. AIMS: We investigated Cx32 expression patterns and semiquantitatively assessed Cx32 expression in cancers and preneoplastic lesions. To determine if cell proliferation is correlated with Cx32 expression, we evaluated Ki67 expression in a gastric cancer mouse model.
METHODS: In human and mouse, normal stomach and gastric adenocarcinoma tissues were used for immunohistochemical analyses.
RESULTS: Cx32 was detected at cell-cell (intercellular) contact points in normal cells and exhibited punctate intercellular and intracytoplasmic staining in cancer cells. The frequency of Cx32 loss of expression was significantly higher in human adenocarcinomas than in normal stomach. As tumor cells were less differentiated, Cx32 expression levels and intercellular and intracytoplasmic staining were also significantly lower. The Cx32 expression pattern in the mouse gastric cancer model was similar in several important respects to that of human. In mucous metaplasia of the mouse stomach, Cx32 was mainly expressed in the cytoplasm of epithelial cells. There was also an inverse correlation between Cx32 expression and cell proliferation in mouse tumors. However, there was no difference in the levels of Cx32 mRNA between normal and cancerous tissues.
CONCLUSIONS: These findings suggest that altered Cx32 expression, a loss of intercellular Cx32 and a gain of intracytoplasmic Cx32 in the form of punctate "dot", plays an important role in the formation of gastric adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21082351     DOI: 10.1007/s10620-010-1467-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  39 in total

Review 1.  Structural and functional diversity of connexin genes in the mouse and human genome.

Authors:  Klaus Willecke; Jürgen Eiberger; Joachim Degen; Dominik Eckardt; Alessandro Romualdi; Martin Güldenagel; Urban Deutsch; Goran Söhl
Journal:  Biol Chem       Date:  2002-05       Impact factor: 3.915

Review 2.  Epigenetic regulation of gap junctional intercellular communication: more than a way to keep cells quiet?

Authors:  Mathieu Vinken; Evelien De Rop; Elke Decrock; Elke De Vuyst; Luc Leybaert; Tamara Vanhaecke; Vera Rogiers
Journal:  Biochim Biophys Acta       Date:  2008-08-29

3.  Estimates of the worldwide frequency of sixteen major cancers in 1980.

Authors:  D M Parkin; E Läärä; C S Muir
Journal:  Int J Cancer       Date:  1988-02-15       Impact factor: 7.396

4.  Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.

Authors:  Bomi Kim; Sun-Ju Byun; Young A Kim; Ji Eun Kim; Byung Lan Lee; Woo Ho Kim; Mee Soo Chang
Journal:  Pathology       Date:  2010-01       Impact factor: 5.306

5.  Suppression of human prostate cancer cell growth by forced expression of connexin genes.

Authors:  P P Mehta; C Perez-Stable; M Nadji; M Mian; K Asotra; B A Roos
Journal:  Dev Genet       Date:  1999

6.  Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.

Authors:  Yuichi Nakashima; Takashi Ono; Akira Yamanoi; Osama Nazmy El-Assal; Hitoshi Kohno; Naofumi Nagasue
Journal:  J Gastroenterol       Date:  2004-08       Impact factor: 7.527

7.  Immunohistochemistry of gap junctions in normal and diseased gastric mucosa of humans.

Authors:  Y Uchida; K Matsuda; K Sasahara; H Kawabata; M Nishioka
Journal:  Gastroenterology       Date:  1995-11       Impact factor: 22.682

8.  Pathological significance of connexin 26 expression in colorectal adenocarcinoma.

Authors:  Ran Hong; Sung-Chul Lim
Journal:  Oncol Rep       Date:  2008-04       Impact factor: 3.906

9.  Correlation between connexin 26 expression and poor prognosis of esophageal squamous cell carcinoma.

Authors:  Takanori Inose; Hiroyuki Kato; Hitoshi Kimura; Ahmad Faried; Naritaka Tanaka; Makoto Sakai; Akihiko Sano; Makoto Sohda; Masanobu Nakajima; Yasuyuki Fukai; Tatsuya Miyazaki; Norihiro Masuda; Minoru Fukuchi; Hiroyuki Kuwano
Journal:  Ann Surg Oncol       Date:  2009-03-27       Impact factor: 5.344

Review 10.  Gap junctions and cancer: new functions for an old story.

Authors:  Laurent Cronier; Sophie Crespin; Pierre-Olivier Strale; Norah Defamie; Marc Mesnil
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

View more
  9 in total

1.  Connexin 32 overexpression increases proliferation, reduces gap junctional intercellular communication, motility and epithelial-to-mesenchymal transition in Hs578T breast cancer cells.

Authors:  Deniz Ugur; Taha Bugra Gungul; Simge Yucel; Engin Ozcivici; Ozden Yalcin-Ozuysal; Gulistan Mese
Journal:  J Cell Commun Signal       Date:  2022-07-04       Impact factor: 5.908

Review 2.  Connexin 43 a check-point component of cell proliferation implicated in a wide range of human testis diseases.

Authors:  Daniel Chevallier; Diane Carette; Dominique Segretain; Jérome Gilleron; Georges Pointis
Journal:  Cell Mol Life Sci       Date:  2012-08-24       Impact factor: 9.261

Review 3.  Connexin and pannexin signaling in gastrointestinal and liver disease.

Authors:  Michaël Maes; Sara Crespo Yanguas; Joost Willebrords; Bruno Cogliati; Mathieu Vinken
Journal:  Transl Res       Date:  2015-05-16       Impact factor: 7.012

4.  Altered expression pattern of molecular factors involved in colonic smooth muscle functions: an immunohistochemical study in patients with diverticular disease.

Authors:  Letizia Mattii; Chiara Ippolito; Cristina Segnani; Barbara Battolla; Rocchina Colucci; Amelio Dolfi; Gabrio Bassotti; Corrado Blandizzi; Nunzia Bernardini
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

5.  PBX1 attributes as a determinant of connexin 32 downregulation in Helicobacter pylori-related gastric carcinogenesis.

Authors:  Xiao-Ming Liu; Can-Xia Xu; Lin-Fang Zhang; Li-Hua Huang; Ting-Zi Hu; Rong Li; Xiu-Juan Xia; Lin-Yong Xu; Ling Luo; Xiao-Xia Jiang; Ming Li
Journal:  World J Gastroenterol       Date:  2017-08-07       Impact factor: 5.742

6.  Petri Net-Based Model of Helicobacter pylori Mediated Disruption of Tight Junction Proteins in Stomach Lining during Gastric Carcinoma.

Authors:  Anam Naz; Ayesha Obaid; Faryal M Awan; Aqsa Ikram; Jamil Ahmad; Amjad Ali
Journal:  Front Microbiol       Date:  2017-09-06       Impact factor: 5.640

7.  Expression and Significance of MyD88 in Patients With Gastric Cardia Cancer in a High-Incidence Area of China.

Authors:  Jingyao Chen; Di Xia; Muming Xu; Ruibing Su; Wenting Lin; Dan Guo; Guangcan Chen; Shuhui Liu
Journal:  Front Oncol       Date:  2020-05-14       Impact factor: 6.244

Review 8.  How does Helicobacter pylori cause gastric cancer through connexins: An opinion review.

Authors:  Huan Li; Can-Xia Xu; Ren-Jie Gong; Jing-Shu Chi; Peng Liu; Xiao-Ming Liu
Journal:  World J Gastroenterol       Date:  2019-09-21       Impact factor: 5.742

9.  Connexin32 inhibits gastric carcinogenesis through cell cycle arrest and altered expression of p21Cip1 and p27Kip1.

Authors:  Hyang Jee; Su-Hyung Lee; Jun-Won Park; Bo-Ram Lee; Ki-Taek Nam; Dae-Yong Kim
Journal:  BMB Rep       Date:  2013-01       Impact factor: 4.778

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.